microRNA Clinical News

by Chris on March 29, 2010

in News

Regulus Therapeutics and Collaborators Publish Pre-clinical In Vivo Efficacy Data on microRNA Therapeutics targeting microRNA-10b in Models of Breast Cancer Metastasis

March 29, 2010 8:00 AM EDT

- New Paper Published in Nature Biotechnology Reports Therapeutic Efficacy of Targeting miR-10b as a New Anti-Metastatic Agent -

CARLSBAD, Calif.–(BUSINESS WIRE)– Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.  (read more)

Rosetta Genomics Announces Publication of the Development and Validation Process of miRview(TM) mets in Modern Pathology

miRview(TM) mets, the first microRNA-based test for identifications of primary origin of metastases, measures the expression levels of 48 microRNAs to identify 25 different primary origins

REHOVOT, Israel & PHILADELPHIA, Mar 29, 2010 (BUSINESS WIRE) — –Designed to assist patients and physicians diagnose cases of cancer of unknown primary (CUP), or cases where the origin of the metastasis is difficult to identify

–Test shown to have sensitivity of 85%-90%, and specificity of 97%-99%

Rosetta Genomics, Ltd. (ROSG 2.12, +0.14, +7.07%) , a leading developer and provider of microRNA-based molecular diagnostics, announces publication of an article describing the development and validation process of miRview(TM) mets, the company’s microRNA-based test for identification of primary origin of metastases. The article, “Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin,” was published on March 26th in the online issue of Modern Pathology, a peer-reviewed publication.  (read more)

Rosenwald et al. (2010) Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Modern Pathology [Epub ahead of print]. [abstract]

Incoming search terms for this article:

Leave a Comment

Previous post:

Next post: